Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Deprivation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02814968
What this trial is testing

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
The European Uro-Oncology Group 66
Post-approval studies (Phase 4)Study completedNCT02726009
What this trial is testing

A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 230
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Not applicableStudy completedNCT02366494
What this trial is testing

Micro RNAs to Predict Response to Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 42
Not applicableLooking for participantsNCT06473259
What this trial is testing

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Santa Chiara Hospital 3,000
Not applicableLooking for participantsNCT06661122
What this trial is testing

Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Low-volume Metastasis
Bayer 100
Large-scale testing (Phase 3)Study completedNCT00089674
What this trial is testing

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 1,468
Testing effectiveness (Phase 2)Looking for participantsNCT06397703
What this trial is testing

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
NYU Langone Health 392
Testing effectiveness (Phase 2)Active Not RecruitingNCT02972060
What this trial is testing

ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 61
Testing effectiveness (Phase 2)Study completedNCT01751438
What this trial is testing

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 180
Not applicableLooking for participantsNCT02997709
What this trial is testing

Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients

Who this might be right for
Prostate Cancer
University of Miami 144
Not applicableActive Not RecruitingNCT05096338
What this trial is testing

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

Who this might be right for
Prostate CancerCardiotoxicityDrug-Related Side Effects and Adverse Reactions+1 more
Abramson Cancer Center at Penn Medicine 200
Large-scale testing (Phase 3)Study completedNCT01020448
What this trial is testing

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 339
Testing effectiveness (Phase 2)Active Not RecruitingNCT03361735
What this trial is testing

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
City of Hope Medical Center 25
Not applicableLooking for participantsNCT04775355
What this trial is testing

Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v7Stage II Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7+3 more
City of Hope Medical Center 30
Not applicableNot Yet RecruitingNCT07311915
What this trial is testing

Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

Who this might be right for
Prostate Cancer
Zhongda Hospital 30
Large-scale testing (Phase 3)Study completedNCT04729491
What this trial is testing

EAT-DUTA AndroCoV Trial

Who this might be right for
Covid19
Corpometria Institute 138
Testing effectiveness (Phase 2)Study completedNCT03007732
What this trial is testing

Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

Who this might be right for
Prostatic Neoplasms
David Oh 23
Testing effectiveness (Phase 2)UnknownNCT06015321
What this trial is testing

An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma

Who this might be right for
Prostatic Adenocarcinoma
Samsung Medical Center 51
Not applicableStudy completedNCT03321149
What this trial is testing

Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy

Who this might be right for
Prostate CancerProstate NeoplasmCancer+1 more
University of Illinois at Urbana-Champaign 46
Next Page